1.
|
Journal Articles
|
A platelet aggregating substance contained in xanthine oxidase preparation from cow's milk.
(Collaboration)
1982
|
2.
|
Journal Articles
|
Analysis of inhibitory activity of Dilazep (ComelianR) on platelet aggregation
(Collaboration)
1984
|
3.
|
Journal Articles
|
The effect of plasma on platelet function in hypercholesterolemic rabbits and the changes in fatty acid composition of the plasma.
(Collaboration)
1984
|
4.
|
Journal Articles
|
Establishment of enzyme immunoassay of human thrombomodulin in plasma and urine using monoclonal antibodies.
(Collaboration)
1990
|
5.
|
Journal Articles
|
Elevation of plasma thrombomodulin level in diabetic patients with early diabetic nephropathy.
(Collaboration)
1990
|
6.
|
Journal Articles
|
Plasma thrombomodulin levels as an indicator of vascular injury caused by cyclosporine nephrotoxicity.
(Collaboration)
1990
|
7.
|
Journal Articles
|
Thiolprotease inhibitor, EST, can inhibit thrombin-induced platelet activation.
(Collaboration)
1990
|
8.
|
Journal Articles
|
Increased thrombomodulin values in plasma of diabetic men with microangiopathy.
(Collaboration)
1991
|
9.
|
Journal Articles
|
Changes in plasma thrombomodulin antigen in rabbit developing endotoxin-induced dissminated intravascular coagulation and the effect of heparin.
(Collaboration)
1992
|
10.
|
Journal Articles
|
The potent inhibition of Vapiprost, a novel thromboxane A2 receptor antagonist, on the secondary aggregation and ATP release of human platelets.
(Collaboration)
1997
|
11.
|
Journal Articles
|
Characterization of soluble thrombomodulin fragments in human urine.
(Collaboration)
1998
|
12.
|
Journal Articles
|
Oxidized low-density lipoprotein impairs the anti-coagulant function of tissue-factor-pathway inhibitor through oxidative modification by its high association and accelerated degradation in cultured human endothelial cells.
(Collaboration)
2000
|
13.
|
Journal Articles
|
Oxidation products of phospholipid-containing delta-9 fatty acids specifically impair the activity of tissue factor pathway inhibitor.
(Collaboration)
2002
|
14.
|
Journal Articles
|
Oxidized low-density lipoprotein associates strongly with carboxy-terminal domain of tissue factor pathway inhibitor and reduces the catalytic activity of the protein.
(Collaboration)
2002
|
15.
|
Journal Articles
|
Oxidized phospholipids in oxidized low-density lipoprotein reduce the activity of tissue factor pathway inhibitor through association with its carboxy-terminal region.
(Collaboration)
2004
|
16.
|
Journal Articles
|
Drinking water quality from the aspect of element concentrations.
(Collaboration)
2006
|
5 display
|
All display(16)
|